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ABSTRACT CCRF-CEM is a human T-cell line originally
isolated from a child with acute lymphoblastic leukemia. At cell
densities > 2 x 10 cells per ml, CEM cells grow in serum-free
medium, but at lower cell densities the cultures rapidly undergo
apoptosis, or programmed cell death. The viability of low-
density CEM cells could be preserved by supplementing the
serum-free medium with "conditioned" medium from high-
density CEM cultures, but a variety of known growth factors
and lymphokines were ineffective. Fractionation ofconditioned
medium by sequential chromatography on DEAE-cellulose,
propyl agarose, chromatofocusing, and hydrophobic-inter-
action HPLC resulted in the isolation of a 60-kDa protein
capable ofsustaining CEM growth in the absence ofserum. The
active protein was identified as human catalase based on its
amino acid sequence and composition and was subsequently
shown to exhibit catalase activity and to be replaceable by
human erythrocyte catalase or bovine liver catalase. Compar-
ison of the level of intracellular catalase activity with the
amount released into the culture medium demonstrated that
the latter accounted for <3% of the total catalase activity
present in the cell culture. These findings show that, despite its
low amount, the catalase released by CEM cells, and perhaps
by T cells in general, provides a critical rust Ilne of defense
against hydrogen peroxide (11202) present in the extracellular
milieu.
Survival in aerobic conditions has required that organisms
develop elaborate antioxidant defense systems to cope with
potentially toxic reactive oxygen species (ROS) (1). For
example, hydrogen peroxide (H202) is generated from nu-
merous endogenous and exogenous sources including mito-
chondrial respiration, UV radiation, peroxigenic bacteria,
and, in the immune system, from the combined actions of the
NADPH oxidase and superoxide dismutase systems of
phagocytes (1, 2). It has recently become apparent that ROS
can have divergent effects on mammalian cell growth. In
some cases low doses of H202 induced cells to undergo
apoptosis, or programmed cell death (3), whereas in other
cases H202 was found to promote cell proliferation (4-7).
Such findings suggest that ROS may function as intracellular
second messengers (8) and that growth stimulation may occur
when cells are protected against excessive ROS toxicity (7).
Both prokaryotes and eukaryotes produce catalase, an
enzymatic antioxidant that effilciently breaks down H202 into
H20 and 02. However, the extensive involvement of the
glutathione peroxidase system for intracellular H202 detox-
ification in cells of higher organisms (9), coupled with the
tenet that catalase activity is restricted to peroxisomes (7),
raises the question as to what role extraperoxisomal catalase
plays in antioxidant defense (10). We report here that CCRF-
CEM, an acute T-lymphocytic leukemia cell line (11), dis-
plays density-dependent growth characteristics in response
to cell-derived extracellular catalase and rapidly undergoes
apoptosis when cultured below a critical cell density. These
results are discussed in the context ofa possible relevance of
extracellular antioxidant production to normal T-cell func-
tion and the etiology of leukemogenesis.
MATERIALS AND METHODS
Cell Lines and Culture Conditions. The CCRF-CEM (11)
and MOLT-4 (12) T-cell acute lymphoblastic leukemia cell
lines were obtained from the American Type Culture Col-
lection. A3.01, a derivative ofCCRF-CEM (13) was obtained
from the AIDS Research and Reference Reagent Program,
Division of AIDS, National Institute of Allergy and Infec-
tious Diseases. The T-cell lines were maintained in a de-
scribed (14) serum-free medium (BHITS) consisting ofRPMI
1640 medium supplemented with 0.1% bovine serum albumin
(Sigma A6003), 10 mM Hepes (pH 7.2), bovine pancreatic
insulin [Intergen 4501 (Purchase, NY)] and human apotrans-
ferrin (Intergen 4450) each at 5 jug/ml, and sodium selenite at
5 ng/ml (Sigma). Cells were cultured at 37°C in a humidified
incubator containing 6% C02/94% air. Cultures were rou-
tinely passed 1:5 every 4-5 days to maintain cell densities of
0.4-2 x 106 cells per ml.
For large-scale production of conditioned medium (CM),
the A3.01 cell line was generally used, and the culture
conditions and medium were modified as follows. Four-liter
cultures of A3.01 cells grown in the serum-free medium were
added to 16 liters of RPMI 1640 medium containing 10 mM
Hepes and insulin and transferrin each at 1.5 jug/ml. The cells
were then cultured statically in 150-cm2 flasks for 6 days, at
which time the flasks were stood on end, and incubation was
continued. After 24 hr the CM was removed by aspiration.
CEM Cell Bioassay. CEM cells from 5-day-old serum-free
cultures were used in the bioassay. The cells were washed
twice with medium, resuspended in the same medium to a cell
density of 1 x 105 cells per ml, and added in 0.1-ml aliquots
to round-bottomed 96-well culture plates containing dupli-
cate 0.1-ml samples to be tested for growth-promoting activ-
ity. After 24 (or in some cases, 48) hr, cultures were treated
with 0.5 uCi per well of [3H]thymidine (New England Nu-
clear, 1 Ci = 37 GBq) for 4-6 hr and harvested onto a glass
filter with a PHD sample harvestor (Cambridge Technology,
Cambridge, MA); the incorporated radioactivity was then
measured by liquid scintillation counting.
Viability Assays. Assay ofCEM cell viability was based on
the ability of the cells to reduce 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) (15). CEM cells
grown in 1% fetal bovine serum/RPMI 1640 medium were
pelleted, washed once with serum-free medium, and cultured
Abbreviations: CM, conditioned medium; HIC, hydrophobic-
interaction chromatography; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; ROS, reactive oxygen species; HP60,
60-kDa hydrophobic protein.
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in round-bottom 96-well plates at a cell concentration of 2 x
105 cells per ml in 0.2 ml of either serum-free medium or
serum-free medium supplemented with 40% CM. At hourly
intervals thereafter, 20 ,ul of an aqueous MTT stock solution
(5 mg/ml) was added to triplicate wells of each culture
condition. After 3-hr incubation, 0.1 ml of medium was
removed from each well, and 0.1 ml of0.5% HCl/isopropanol
was added to lyse the cells. After an additional 10-min
incubation at 37°C, the absorbance at 570 nm was read by
using an Anthos model 2001 ELISA plate reader.
Purification of Lymphoid Catalase. A3.01 cells were gen-
erally used as a source ofCM (A3.01-CM) because these cells
seemed to survive better in high-density, serum-free cultures
than CEM cells. Typically, 20 liters of A3.01-CM were
collected by aspiration, passed through a 5-,um filter to
remove residual cells, and concentrated to -150 ml by using
an Amicon YM-30 filter. The crude concentrate was dialyzed
overnight against two 4-liter changes of 25 mM Hepes, pH
7.0, and applied at a flow rate of 2 ml/min to a DEAE-
cellulose (Whatman) column (80-ml bed volume) previously
equilibrated with 25 mM Hepes, pH 7.0. The column was
washed with the equilibration buffer until the OD280 reading
returned to baseline. A 320-ml linear gradient up to 0.5 M
NaCl in 25mM Hepes, pH 7.0, was then initiated, and column
fractions were assayed directly for activity with the CEM
bioassay. The activity eluted within the first 70 ml, resolving
it from -98% of the starting protein and, in particular, from
the bovine serum albumin in the serum-free medium. Am-
monium sulfate was added directly to the pooled, active
material from the DEAE-cellulose column to yield a final
concentration of 1.4 M, and the material was loaded at a flow
rate of 2 ml/min onto a propyl-agarose (Sigma) column (50-ml
bed volume) previously equilibrated with buffer A [0.1 M
sodium phosphate buffer, pH 7.2/1.4 M (NH4)2SO4]. Un-
bound material was eluted by washing the column with two
bed volumes ofbuffer A, and bound proteins were eluted with
a 250-ml linear gradient up to 100% of buffer B (0.1 M sodium
phosphate, pH 7.2/12.5% isopropanol). Column fractions
containing the activity were pooled and filter-dialyzed into 25
mM triethanolamine buffer, pH 8.3, containing 0.3% octyl-
,3-D-glucopyranoside with an Amicon Centriprep 10 concen-
trator. The recovered material, which represented -2% of
the post-DEAE protein, was applied to a Mono P 5/20
column (Pharmacia) equilibrated in the same buffer and
chromatofocused by using polybuffer 96/74, pH 5.0, con-
taining 0.3% octyl-p-D-glucopyranoside at a flow rate of 1
ml/min. Column effluent was monitored at 280 nm, and 1-ml
fractions were collected and assayed directly for activity. The
activity eluted over a pH range of 6.3-6.8, coinciding with
three minor peaks of protein that accounted for 8% of the
protein carried over from the propyl-agarose column. Am-
monium sulfate was added to active fractions to yield a 1 M
final concentration; the fractions were then individually
injected onto a Synchropac propyl hydrophobic-interaction
chromatography (HIC) HPLC column (250 x 4.8 mm) equil-
ibrated with 70% buffer A [0.1 M sodium phosphate buffer,
pH 7.2/2.0 M (NH4)2SO4] and 30o buffer B (0.1 M sodium
phosphate buffer, pH 7.2/12.5% isopropanol). A 25-min
linear gradient up to 100% of buffer B was initiated immedi-
ately upon sample injection. Column effluent was monitored
at 230 nm, and 1-ml fractions were collected and assayed
directly for activity. HIC HPLC of the two fractions corre-
sponding to the middle of the activity peak from the chro-
matofocusing column generated a single, well-resolved, sym-
metrical peak of protein that coincided precisely with the
peak of activity.
Analytical Methods. Reversed-phase HPLC of the post-
HIC HPLC material was done using a Synchropac C-1
reversed-phase column (50 x 4.6 mm) developed with a linear
gradient starting from 95% bufferA (water/0.1% CF3COOH)
and 5% buffer B (isopropanol/0.1% CF3COOH) and in-
creased over 30 min to 100% of buffer B. Protein elution was
monitored at 230 nm. Essentially one protein peak eluted
from the reversed-phase HPLC column, indicating that the
protein obtained after HIC HPLC was purified to homoge-
neity. This result was confirmed by analysis of the post-HIC
and post-reversed-phase HPLC materials by electrophoresis
on 0.1% NaDodSO4/7-20% polyacrylamide gels (16). After
overnight staining with Coomassie blue, a single band of 60
kDa was observed under both reducing and nonreducing
conditions, thus confirming that the four chromatography
steps yielded a single, highly purified protein capable of
sustaining CEM growth in serum-free medium.
Assay of Catalase Activity. Catalase activity was quantified
by measuring the rate of H202 catabolism as indicated by a
decrease in absorbance at 240 nm (17).
Cyanogen Bromide Cleavage. Cyanogen bromide (CNBr)
cleavage was done on 200 pmol of purified protein (18). The
resulting fragments were separated by Tricine/NaDodSO4/
PAGE (16.5% T, 3% C) (19), electroblotted onto a poly(vi-
nylidene difluoride) protein-sequencing membrane, and
stained with Coomassie blue.
Apoptosis Assay. DNA fragmentation was assayed by using
a procedure adapted from Hogquist et al. (20). Briefly, 2 x 106
cells were pelleted and resuspended in 500 ,ul of ice-cold lysis
buffer (20 mM Tris HCl, pH 7.4/10 mM EDTA/0.2% Triton
X-100) for 10 min, followed by centrifugation (10,000 rpm for
10 min). Proteinase K was added to the supernatant (100
,ug/ml), which was then incubated at 50°C for 6 hr, followed
by the addition ofRNase A and further incubation at 37°C for
2 hr. Fragmented DNA was extracted twice with phenol,
extracted once with chloroform/isoamyl alcohol, 24:1, and
precipitated overnight at -20°C with 50%o isopropanol/
glycogen at 5 ,ug/ml. The DNA fragments were electropho-
resed through a 1.25% agarose gel and stained with ethidium
bromide.
Amino Acid Analysis and Peptide Sequencing. Amino acid
analysis and sequencing were done at the University of
California at Los Angeles Protein Microsequencing Facility
(Los Angeles).
Materials. Recombinant human interleukins -3, -4, -5, -6,
and -8 were provided by the Biological Response Modifiers
Program (National Cancer Institute, Bethesda, MD). Recom-
binant human interleukin 2 was obtained through the AIDS
Research and Reference Reagent Program, Division of
AIDS, National Institute of Allergy and Infectious Diseases.
Recombinant human interleukin 7 was purchased from Gen-
zyme. Human erythrocyte catalase was purchased from
Calbiochem, and bovine liver catalases were obtained from
Worthington and Sigma.
RESULTS
Autocrine Growth of CCRF-CEM. We previously reported
that CEM cells could be grown in a serum-free medium
consisting of RPMI 1640 supplemented with bovine serum
albumin, insulin, transferrin, and selenium (14). However, in
subsequent studies it was noted that the ability of CEM cells
to proliferate in serum-free medium was cell-density-
dependent (Fig. 1). CEM cells proliferated when inoculated
at cell densities > 2 x 105 cells per ml but did not proliferate
at lower cell densities. By contrast, MOLT-4, a T-cell lineage
distinct from CCRF-CEM, grew in the serum-free medium at
every cell density tested (Fig. 1).
Density-dependent growth has, in some cases, been attrib-
uted to the secretion of one or more essential cell-derived
proteins (21, 22). Fig. 2 shows that the addition of CM from
high-density (2-3 x 106 cells per ml) CEM cultures (CEM-
CM) sustained CEM cell proliferation at the normally non-
permissive cell density of 5 x 104 cells per ml. By contrast,
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FIG. 1. Density dependence of CEM proliferation. CEM and
MOLT-4 cells were cultured in serum-free media at the indicated cell
densities. After 72 hr, cultures were treated for 4 hr with [3H]thy-
midine.
CEM cells cultured at 5 x 104 cells per ml in the absence of
CM or serum supplements underwent a rapid loss of viability
(Fig. 3A) with accompanying morphological changes (Fig.
3B) and DNA degradation (Fig. 3C) characteristic of apo-
ptosis (23). Collectively, the data shown in Figs. 1-3 are
consistent with CEM cells having a requirement for one or
more cell-derived factors to survive in the absence of serum
supplements.
A variety of recombinant human cytokines were tested for
their ability to sustain CEM proliferation in serum-free me-
dium; recombinant human interleukins 2 through 8 were
ineffective, as were a variety of other known growth factors
(data not shown).
Purification of 60-kDa Hydrophobic Protein (HP60). The
inability of CEM cells to proliferate in serum-free medium
when plated at low cell densities facilitated development of a
bioassay that was used to assay column fractions for growth-
promoting activity. As described in Materials and Methods,
growth-promoting activities were routinely quantified by
measurements of [3H]thymidine uptake, but visual inspection
of the cultured cells (Fig. 3B) also provided a rapid and
sensitive assessment of activity during the purification pro-
cess. Purification of the required factor was accomplished
starting with 20 liters of A3.01-CM, which contained -4 g of
starting protein. The purification protocol developed in-
volved four chromatographic steps (Fig. 4) and yielded =35
jig of a HP60 having a pl of 6.3-6.8.
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FIG. 2. Factor dependency of CEM. CEM cells were cultured at
a density of 5 x 104 cells per ml in serum-free medium containing the
indicated concentrations of CEM-CM. After 24 hr the cultures were
treated for 4 hr with [3H]thymidine.
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FIG. 3. CEM viability and morphology in serum-free medium.
(A) CEM cells were cultured at a density of 5 x 104 cells per ml in
either serum-free medium (BHITS) or serum-free medium containing
40%o CEM-CM. Immediately afterward and at hourly intervals there-
after, culture aliquots were removed, MTT was added, and cell
viability was assayed 4 hr later. (B) CEM cells were cultured at a
density of 5 x 104 cells per ml for 15 hr in serum-free medium either
lacking (Upper) or containing (Lower) 40% CEM-CM. (C) CEM cells
were cultured at a density of 5 x 104 cells per ml in serum-free
medium either lacking (-) or containing (+) 40%6 CEM-CM. After 18
hr, the cells were harvested and assayed forDNA fragmentation. The
four low-molecular-size markers (outer lanes) range from 0.3 to 1.4
kb.
Identification of HP60 as Catalase. An initial attempt to
obtain the N-terminal amino acid sequence ofHP60 suggested
that its N terminus was blocked. Accordingly, HP60 was
treated with CNBr followed by recovery of a =5-kDa peptide
that was subjected to automated sequencing. The 21-amino
acid sequence Leu-Gln-Gly-Arg-Leu-Phe-Ala-Tyr-Pro-[?]-
Thr-His-Arg-His-Arg-Leu-Gly-Pro-Asn-Tyr-Leu was ob-
tained and found to correspond to region 350-370 of human
catalase (24). Further confirmation ofHP60 as human catalase
was based on its total amino acid composition (25) and its
ability to degrade H202 (17).
Biological Activity of Lymphoid Catalase. Dose-response
studies were done by using theCEM cell bioassay to compare
the ability of the purified lymphoid catalase (HP60) with
commercially obtained human erythocyte catalase. When
titrated on the basis of their catalase activities (units/ml),
both lymphoid and erythrocyte catalases were found equally
effective in supporting CEM cell growth (Fig. 5). Virtually
identical results were obtained with bovine liver catalases of
various degrees of purity, obtained from two different com-
mercial sources (data not shown).
Finally, studies were done to compare the amount of
catalase activity released by CEM cells into the culture
medium with the amount of catalase retained intracellularly.
Five milliliters ofCEM culture containing 2 x 106 cells per ml
was concentrated 5-fold by ultrafiltration, and after the
addition of Triton X-100 (0.5% final concentration) to release
intracellular catalase, the total amount of catalase activity
measured was 0.081 units per 5-ml culture. Surprisingly,
>97% ofthe activity was associated with the cell pellet (0.078
unit per 1 x 107 cells), whereas the level of activity in the
culture medium (concentrated 5-fold) was below the limit of
detection. This finding indicates that despite a large excess of
intracellular catalase, it is the minute amount of extracellular
catalase that is necessary to protect CEM cells from the
cytotoxic effects of extracellular H202.
DISCUSSION
The requirement for oxygen radical scavengers and/or re-
ducing agents in both serum-containing and serum-free me-
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FIG. 4. Purification of HP60. (A) Concentrated A3.01-CM was applied to a DEAE-celiulose column, and bound proteins were eluted with
a linear gradient of 0-0.5 M NaCl. (B) Pooled fractions of activity from the DEAE column were applied to a propyl-agarose column, followed
by elution with decreased ammonium sulfate to 0 M and a simultaneous increase of isopropanol to 12.5%. (C) Active fractions from the
propyl-agarose column were pooled and chromatofocused on a Mono P column with apH interval between 5.0 and 8.3 by using an HPLC system.
(D) Active fractions from the Mono P column were applied in 2-ml aliquots to a Synchropak propyl-HIC HPLC column and eluted with decreased
ammonium sulfate to 0 M and increased isopropanol to 12.5%. The peak that eluted between 3 and 9 min contained primarily ampholytes from
the chromatofocusing step. Fractions containing HP60 activity are indicated by the hatched bars.
dium is well established. It has previously been reported that
the addition of exogenous catalase facilitates the growth of
lymphoid cells in serum-free medium (26, 27). Those reports,
however, did not provide any evidence that cells oflymphoid
origin when cultured at a suitably high density had the
potential to condition the growth medium with catalase, or
any other antioxidant for that matter. We report here that the
density-dependent growth of the CCRF-CEM lymphocytic
leukemia cell line in serum-free medium is the result of a
requirement for extracellularly released catalase. The appar-
ent inability of large quantities of cell-associated catalase to
prevent apoptosis of individual CEM cells in cultures below
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FIG. 5. Titration of lymphoid and erythrocyte catalases in the
CEM bioassay. GEM cells cultured at 5 x 10 cells per ml in
serum-free medium were additionally supplemented with the indi-
cated concentrations of either purified lymphoid catalase (HP60) or
human erythrocyte catalase (HEC). After 48 hr, cultures were
treated for 5 hr with [3H]thymidine to assay DNA synthesis.
a critical cell density suggests a requirement for a relatively
minute quantity of extracellular catalase to protect against
either H202-mediated plasma membrane damage or by acting
on a trace medium component necessary for cell growth.
Possible sources of H202 in CEM cultures include endoge-
nous production of ROS (2, 4, 5) and small amounts of H202
probably present in tissue culture medium (2, 26).
The results described here provide evidence of a leukemic
cell line that has an obligate autocrine-like dependence for
endogenously produced and extracellularly released cata-
lase. In this regard, it is interesting to note that adult T-cell
leukemia-derived factor, an autocrine growth factor, is a
homologue of thioredoxin, an enzyme involved in numerous
dithiol-dependent reducing processes, and which can catab-
olize H202 (28). Similar to our observations with extracellular
catalase, adult T-cell leukemia-derived factor/thioredoxin
acts as an autocrine growth factor for Epstein-Barr virus-
transformed B-cell lines and facilitates the growth of adult
T-cell leukemia cells in low-serum tissue culture (28). Thio-
redoxin appears to function as an endogenous reducing agent
in the process of lymphocyte transformation and activation
(28). Hence, autocrine production of extracellular antioxi-
dants, such as catalase and thioredoxin, may play an impor-
tant role in leukemogenesis.
It has generally been accepted that catalase provides little
protection against extracellular H202 because the enzyme is
predominantly located in peroxisomes (7, 10) and is thought
not to be secreted (29). Nevertheless, the present findings
with CEM cells when coupled with the reported secretion of
thioredoxin by human T-lymphotropic virus I-infectedT cells
(28) suggest that cells ofT helper origin may have the capacity
to export functional antioxidant enzymes. Indeed, T helper
cells have been reported to be less sensitive to H202-induced
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damage than other lymphoid cells, a feature that may be
crucial for their ability to survive and function in close
proximity to activated macrophages and neutrophils at sites
of chronic inflammation (30). In addition, extracellular cat-
alase has been shown to augment a number of T-cell activ-
ities, including mixed lymphocyte reactions (31), erythrocyte
rosette formation (32), and proliferative responses to phorbol
12-myristate 13-acetate-stimulated macrophages (33). Thus,
the observations that some CD4+ T-cell lines grow in re-
sponse to extracellular catalase/thioredoxin may have im-
portant implications for the functioning of T-helper cells in
vivo. At or above a critical cell density T helper cells may,
through the release of extracellular antioxidants, augment a
local immune response by enhancing cell viability and func-
tion. Conversely, impaired antioxidant production and/or
secretion may be associated with a loss ofCD4 T-cell viability
or function. It was recently reported that human immunode-
ficiency virus infection is associated with decreased thiore-
doxin levels (34). Consistent with that observation, we have
recently observed that human immunodeficiency virus gene
expression in variants ofthe CEM cell lineage results in a loss
of their ability to grow in serum-free conditions, even at
relatively high cell densities (35). This impaired growth in
serum-free medium was shown to result from a diminished
ability of human immunodeficiency virus-expressing cells to
condition the medium with catalase.
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